Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board
Sponsor: Teresa Woorman (District 16)Committee: HealthSubject: Health - InsuranceStatus: Unfavorable Report by Health; Withdrawn (as of Sep 4, 2026)
What this bill does
Official synopsis
Prohibiting a managed care organization and certain insurers, nonprofit health service plans, and health maintenance organizations from requiring a prior authorization or step therapy or fail-first protocol under certain circumstances for prescription drugs that have been reviewed by the Prescription Drug Affordability Board; etc.
AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (0)
MGA witness listNo witness list on file because no hearing has been scheduled.